Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Grifols SA (NASDAQ:GRFS)

16.10
Delayed Data
As of May 27
 +0.13 / +0.81%
Today’s Change
14.07
Today|||52-Week Range
18.04
-0.62%
Year-to-Date
GRFS Regular Dividend: GRFS will begin trading ex-dividend on 06/02/16 with a $0.1586 dividend payable to shareholders of record as of 06/06/16.
No recent news for Grifols SA.

Today’s Trading

Previous close15.97
Today’s open15.99
Day’s range15.87 - 16.16
Volume1,526,105
Average volume (3 months)1,324,986
Market cap$4.1B
Dividend yield2.26%
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-5.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.80%
Revenue growth (last year)-2.06%
P/E ratio--
Price/Sales2.56
Price/Book3.07

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...+0.71+2.03%
NBIXNeurocrine Bioscienc...+0.36+0.79%
ANACAnacor Pharmaceutica...-0.64-0.64%
AKRXAkorn Inc+0.41+1.38%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$0.27
Annual revenue (last year)$4.3B
Annual profit (last year)$587.3M
Net profit margin13.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Víctor Grifols Roura
Chief Financial Officer &
Vice President
Alfredo Arroyo Guerra
Corporate headquarters
Barcelona, Catalonia

Forecasts

Partner Offers

Search for Jobs